Barbara‐ann Guinn

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up

Barbara‐ann Guinn, AI Al-Sabah, M. T. Smith et al. · Leukemia · 1998 · 213 citations

Hematological Malignancy, P53 Mutations, Medicine +8

IL‐17‐producing CD4⁺T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

Shahram Kordasti, Behdad Afzali, ZiYi Lim et al. · British Journal of Haematology · 2009 · 191 citations · Full text

Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016

Fidelia Bature, Barbara‐ann Guinn, Dong Pang et al. · BMJ Open · 2017 · 174 citations · Full text

4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine

Barbara‐ann Guinn, Mark DeBenedette, Tania H. Watts et al. · The Journal of Immunology · 1999 · 125 citations · Full text

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia

Barbara‐ann Guinn, Elizabeth A. Bland, Usman Lodi et al. · Biochemical and Biophysical Research Communications · 2005 · 80 citations

Hematological Malignancy, Immunocytochemical Technique, Medicine +9